Latest FluoGuide News & Updates

See the latest news and media coverage for FluoGuide. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
FluoGuide

Biotechnology company developing fluorescent cancer surgery drugs

fluoguide.com
Headquarters
Copenhagen, Denmark
Founded year
2018
Company type
Private company
Number of employees
2–15

Last updated

Latest news about FluoGuide

In short: FluoGuide reported positive interim trial results for FG001 and secured FDA Fast Track Designation for its use in high-grade glioma surgery.

Company announcements

  • FluoGuide

    FluoGuide presents positive interim FG001 study results

    Dr. Jane Skjøth-Rasmussen shared data at Brain Tumor Symposium 2026 in Copenhagen, highlighting FG001's potential to improve tumor delineation in meningioma and low-grade glioma surgery.

  • FluoGuide

    FluoGuide presents positive interim FG001 study results

    Interim data show 100% sensitivity in meningioma surgery and encouraging fluorescence in low-grade glioma. Presented at SNOG 2026.

  • FluoGuide

    FluoGuide holds annual general meeting

    The meeting adopts the 2025 annual report, re-elects board members, elects new member Kim D. Kjøller, authorizes warrants, updates articles of association, and approves board remuneration.

  • FluoGuide

    FluoGuide receives FDA Fast Track Designation for FG001

    The designation facilitates FG001's development as an intraoperative imaging agent for high-grade glioma resection. It enables frequent FDA interactions and potential accelerated approval. Phase 2 trial preparation is underway.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about FluoGuide

Track FluoGuide and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.